SHARE

Last February, Imperial Brands PLC, launched their vaping device via subsidiary Fontem Ventures in the US. Myblu is a pod-based system that uses liquid pods instead of the refill cartridges that are normally used in e-cigarettes, which are supposed to make the product perform better.

The study found eight toxicants at quantifiable levels, but these were still found at levels 99% lower than those in conventional cigarette smoke.
Imperial Tobacco, the British multinational cigarette maker, bought out the Austrian vape-product manufacturer earlier this year. Subsequently, Imperial Brands is releasing a campaign to market the product as a safer alternative.

The study entitled “Chemical Composition of myblu™ Pod-System E-Cigarette Aerosols: A Quantitative Comparison with Conventional Cigarette Smoke” analysed 51 toxicants of interest, and found eight at quantifiable levels. These included formaldehyde, acetaldehyde and acrolein, and were still found at levels 99% lower when compared to conventional cigarette smoke.

Switching to e-cigs reduces smokers’ exposure to carcinogens

The aerosol chemistry study was presented last Saturday by Dr Grant O’Connell, Corporate Affairs Manager at Fontem Ventures, the owner of the e-cigarette brand blu. “Consistent with emerging clinical data, this study demonstrates that high quality vaping devices and e-liquids offer the potential to substantially reduce exposure to carcinogens and toxicants in smokers who use them as an alternative to cigarettes,” he said.

The reported levels are in line with those found in studies testing other vaping devices. “Testing of the myblu aerosols indicate low or no detectable levels of the toxicants tested. The total yield was less than 1 microgram per puff of toxicants tested, which is 99% less than the 381 micrograms per puff quantified and published for cigarette smoke,” said Dr O’Connell. “It’s important that governments and health authorities around the world share this information with smokers seeking to replace conventional cigarettes.”

Read Further: EurekAlert

Advertisement

Book your ad here